Health unicorn Alan raises €480m Series G round led by Prosus

· Source: Sifted · Field: Health & Wellbeing — Healthcare Systems & Policy, Medical Devices & Health Technology · Depth: Fundamental Awareness, quick

Summary

Healthtech startup Alan has secured a €480m Series G funding round, elevating its valuation to €5.5bn. Dutch investment giant Prosus led this round. Existing backers Index Ventures and Teachers' Venture Growth participated, joined by new investor Dara Holdings. Founded in 2016, Alan has evolved from a digital health insurer into a comprehensive healthcare platform offering insurance, care, and prevention services. The company leverages an AI-native approach to deliver personalized healthcare experiences and achieve scalable growth. In the first quarter of 2026, Alan reported over €800m in annual recurring revenue, marking a 53% year-on-year increase, and serves more than 1.1 million individuals, achieving profitability in France. Prosus intends to support Alan's international expansion and product development, providing access to its AI capabilities, including its Large Commerce Model.

Key takeaway

For healthtech entrepreneurs seeking significant growth and investment, Alan's €480m Series G round underscores the value of an AI-native, user-centric platform. You should prioritize deeply understanding and rethinking user experience in stagnant sectors. This differentiation attracts major capital and enables rapid scaling. Consider integrating diverse services like insurance, care, and prevention for a comprehensive offering. Utilize AI for personalization and efficiency to achieve profitability and expand internationally.

Key insights

Alan's success stems from an AI-native, user-experience-focused approach to healthtech, attracting significant investment for expansion.

Principles

In practice

Topics

Best for: Investor, Entrepreneur, Executive

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Sifted.